TWO practically-identical woolly jumpers are on sale in different budget high-street chains – with a price €20 apart. The jacquard-print jersey in brown and beige tones is on the shelves in Pull&Bear for €29...
Balenciaga's 'T-shirt shirt' sparks mirth on social media
ONE of Spain's most prestigious haute couture fashion houses has been ridiculed on social media for its latest design – the 'T-shirt shirt'.
This bizarre creation by Balenciaga, which carries the eye-watering price tag of €1,300, is a bright blue short-sleeved T-shirt with a long-sleeved dark-blue checked shirt sewn onto the front of it.
The male model on the Balenciaga website wears the T-shirt with the shirt in front, although it is also designed to be worn the other way around – as a shirt, with a T-shirt sewn onto the back of it.
At first, social media users thought it was a 'fake news' post, until they checked the official site for the fashion house and discovered it was real.
And to top it off, for the same price, a 'double shirt' has now been released – one shirt sewn onto the front of another so that either can be worn with the 'surplus' garment hanging loose at the front or back.
“This isn't fashion, it's just awful,” read one of the comments on Instagram, whilst others said 'garbage' and 'what is that?'
Others say if Balenciaga himself were alive today he would 'turn pale' to see what his old empire was doing in his name.
Cristóbal Balenciaga was born in the Basque Country and lived for many years in Jávea (Alicante province), where he died.
More Health/Beauty/Fashion content
INDITEX heiress Marta Ortega and Carlos Torretta, son of Argentinian fashion designer Roberto, are now married – in a much quieter and more homely ceremony than the former's first wedding to showjumper Sergio...
A TOP name in modern pop has launched her own clothing range at Inditex's budget streetware brand, Pull & Bear. Rosalía, who recently performed live in London and at the MTV Awards, has been described as...
Shares in pharmaceutical multinational Grifols skyrocketed on the Spanish stock exchange on Monday after the company announced the results of a clinical trial of a plasma replacement product that had succeeded in...